nodes	percent_of_prediction	percent_of_DWPC	metapath
Ridogrel—TBXAS1—prostate cancer	0.803	1	CbGaD
Ridogrel—TBXA2R—prostate gland—prostate cancer	0.00896	0.194	CbGeAlD
Ridogrel—TBXAS1—prostate gland—prostate cancer	0.00786	0.17	CbGeAlD
Ridogrel—TBXA2R—epithelium—prostate cancer	0.00658	0.142	CbGeAlD
Ridogrel—TBXA2R—urethra—prostate cancer	0.006	0.13	CbGeAlD
Ridogrel—TBXAS1—bone marrow—prostate cancer	0.00405	0.0877	CbGeAlD
Ridogrel—TBXA2R—testis—prostate cancer	0.00395	0.0853	CbGeAlD
Ridogrel—TBXAS1—testis—prostate cancer	0.00346	0.0749	CbGeAlD
Ridogrel—TBXA2R—lymph node—prostate cancer	0.00286	0.0619	CbGeAlD
Ridogrel—TBXAS1—lymph node—prostate cancer	0.00251	0.0543	CbGeAlD
Ridogrel—Fluvoxamine—CYP3A5—prostate cancer	0.00103	0.266	CrCbGaD
Ridogrel—Fluvoxamine—CYP2E1—prostate cancer	0.000709	0.183	CrCbGaD
Ridogrel—Fluvoxamine—CYP2C19—prostate cancer	0.000702	0.181	CrCbGaD
Ridogrel—Fluvoxamine—CYP1A1—prostate cancer	0.000699	0.18	CrCbGaD
Ridogrel—Fluvoxamine—CYP3A4—prostate cancer	0.000446	0.115	CrCbGaD
Ridogrel—Niflumic Acid—PTGS2—prostate cancer	0.000295	0.076	CrCbGaD
Ridogrel—TBXA2R—Signaling by GPCR—GNRH1—prostate cancer	9.31e-05	0.000633	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PLXNB1—prostate cancer	9.18e-05	0.000624	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—SLC22A3—prostate cancer	9.12e-05	0.00062	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—HSD3B1—prostate cancer	9.12e-05	0.00062	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—LPAR1—prostate cancer	9.01e-05	0.000613	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—GRP—prostate cancer	9.01e-05	0.000613	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PLCB2—prostate cancer	8.92e-05	0.000607	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—GNG5—prostate cancer	8.92e-05	0.000606	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—LPL—prostate cancer	8.85e-05	0.000602	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—VAV3—prostate cancer	8.84e-05	0.000601	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—PIK3CB—prostate cancer	8.84e-05	0.000601	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—GRPR—prostate cancer	8.84e-05	0.000601	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CX3CL1—prostate cancer	8.75e-05	0.000595	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GSTA4—prostate cancer	8.75e-05	0.000595	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—ITPR1—prostate cancer	8.58e-05	0.000583	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	8.55e-05	0.000581	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IL17RD—prostate cancer	8.53e-05	0.00058	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GSTA2—prostate cancer	8.52e-05	0.00058	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PDE4D—prostate cancer	8.51e-05	0.000579	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ABCG5—prostate cancer	8.42e-05	0.000572	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—SULT1A1—prostate cancer	8.42e-05	0.000572	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GSTA1—prostate cancer	8.22e-05	0.000559	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—NAT2—prostate cancer	8.13e-05	0.000553	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GSTO1—prostate cancer	8.13e-05	0.000553	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—HSD3B2—prostate cancer	8.13e-05	0.000553	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—IL2—prostate cancer	8.12e-05	0.000552	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—GNG5—prostate cancer	8.1e-05	0.000551	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	7.82e-05	0.000532	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—LRP2—prostate cancer	7.8e-05	0.00053	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CYP2C18—prostate cancer	7.8e-05	0.00053	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PLCB2—prostate cancer	7.8e-05	0.00053	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PTHLH—prostate cancer	7.77e-05	0.000528	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—P4HB—prostate cancer	7.64e-05	0.00052	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—JUP—prostate cancer	7.61e-05	0.000517	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—WNT4—prostate cancer	7.61e-05	0.000517	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—ITGB3—prostate cancer	7.59e-05	0.000516	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—SLC22A1—prostate cancer	7.44e-05	0.000506	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	7.35e-05	0.0005	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—ANXA1—prostate cancer	7.3e-05	0.000497	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MC2R—prostate cancer	7.26e-05	0.000493	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—RALBP1—prostate cancer	7.26e-05	0.000493	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—SULT2A1—prostate cancer	7.25e-05	0.000493	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—MED12—prostate cancer	7.13e-05	0.000485	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—SRC—prostate cancer	7.09e-05	0.000482	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GNG5—prostate cancer	7.07e-05	0.000481	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PTHLH—prostate cancer	7.05e-05	0.00048	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PRKACB—prostate cancer	6.9e-05	0.000469	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—VEGFA—prostate cancer	6.9e-05	0.000469	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CALCA—prostate cancer	6.84e-05	0.000465	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—NCOA3—prostate cancer	6.81e-05	0.000463	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PPP3CA—prostate cancer	6.73e-05	0.000458	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	6.7e-05	0.000455	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PLAU—prostate cancer	6.69e-05	0.000455	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CXCL12—prostate cancer	6.68e-05	0.000454	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—ANXA1—prostate cancer	6.63e-05	0.000451	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—CAV1—prostate cancer	6.53e-05	0.000444	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—HPGDS—prostate cancer	6.5e-05	0.000442	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PENK—prostate cancer	6.47e-05	0.00044	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CYP2C19—prostate cancer	6.46e-05	0.000439	CbGpPWpGaD
Ridogrel—TBXA2R—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	6.43e-05	0.000437	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—prostate cancer	6.35e-05	0.000432	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	6.33e-05	0.000431	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GSTT1—prostate cancer	6.3e-05	0.000429	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ACHE—prostate cancer	6.3e-05	0.000429	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CYP2A6—prostate cancer	6.23e-05	0.000424	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CALCA—prostate cancer	6.21e-05	0.000422	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	6.21e-05	0.000422	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—GHR—prostate cancer	6.17e-05	0.000419	CbGpPWpGaD
Ridogrel—TBXA2R—G alpha (q) signalling events—PIK3CA—prostate cancer	6.16e-05	0.000419	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PRKCQ—prostate cancer	6.1e-05	0.000414	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CXCL12—prostate cancer	6.07e-05	0.000412	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—AKR1C3—prostate cancer	6.06e-05	0.000412	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PRKACB—prostate cancer	6.03e-05	0.00041	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—prostate cancer	6e-05	0.000408	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CYP17A1—prostate cancer	5.97e-05	0.000406	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PIK3CG—prostate cancer	5.95e-05	0.000404	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NRP1—prostate cancer	5.91e-05	0.000402	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.89e-05	0.0004	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—EGF—prostate cancer	5.88e-05	0.0004	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—ADRB2—prostate cancer	5.73e-05	0.00039	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—NCOA2—prostate cancer	5.69e-05	0.000387	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—VAV3—prostate cancer	5.59e-05	0.00038	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PRKCQ—prostate cancer	5.54e-05	0.000376	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—CREBBP—prostate cancer	5.51e-05	0.000375	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—prostate cancer	5.51e-05	0.000375	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—VIP—prostate cancer	5.5e-05	0.000374	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—GNRH1—prostate cancer	5.5e-05	0.000374	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—IGF1—prostate cancer	5.45e-05	0.00037	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—SLC5A5—prostate cancer	5.43e-05	0.000369	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—ITPR1—prostate cancer	5.42e-05	0.000369	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	5.39e-05	0.000366	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—LPAR1—prostate cancer	5.33e-05	0.000362	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—GRP—prostate cancer	5.33e-05	0.000362	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CYP2E1—prostate cancer	5.3e-05	0.00036	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PLCB2—prostate cancer	5.27e-05	0.000358	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—LRP2—prostate cancer	5.27e-05	0.000358	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—NQO1—prostate cancer	5.24e-05	0.000356	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PIK3CD—prostate cancer	5.23e-05	0.000356	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—ADRB2—prostate cancer	5.2e-05	0.000354	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—SERPINE1—prostate cancer	5.17e-05	0.000352	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CX3CL1—prostate cancer	5.17e-05	0.000352	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—P4HB—prostate cancer	5.17e-05	0.000352	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—TH—prostate cancer	5.16e-05	0.000351	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.13e-05	0.000349	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CYP3A4—prostate cancer	5.11e-05	0.000347	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.08e-05	0.000346	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—VAV3—prostate cancer	5.08e-05	0.000345	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HIST1H2BG—prostate cancer	5.07e-05	0.000345	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—GRB7—prostate cancer	5.03e-05	0.000342	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PDE4D—prostate cancer	5.03e-05	0.000342	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CYP1B1—prostate cancer	5.02e-05	0.000342	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—NOS3—prostate cancer	4.94e-05	0.000336	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—ITPR1—prostate cancer	4.92e-05	0.000335	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HIST1H4H—prostate cancer	4.9e-05	0.000333	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR ligand binding—CXCL8—prostate cancer	4.9e-05	0.000333	CbGpPWpGaD
Ridogrel—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	4.88e-05	0.000332	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GGT1—prostate cancer	4.87e-05	0.000331	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—JAK2—prostate cancer	4.8e-05	0.000326	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—NCOA1—prostate cancer	4.79e-05	0.000326	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—GNG5—prostate cancer	4.78e-05	0.000325	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CYP19A1—prostate cancer	4.72e-05	0.000321	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—RXRA—prostate cancer	4.56e-05	0.00031	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PIK3CB—prostate cancer	4.56e-05	0.00031	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.43e-05	0.000301	CbGpPWpGaD
Ridogrel—TBXA2R—Platelet activation, signaling and aggregation—AKT1—prostate cancer	4.4e-05	0.000299	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—COMT—prostate cancer	4.39e-05	0.000299	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GSTP1—prostate cancer	4.37e-05	0.000297	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ITPR1—prostate cancer	4.3e-05	0.000292	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.23e-05	0.000287	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—IL2—prostate cancer	4.19e-05	0.000285	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PTHLH—prostate cancer	4.17e-05	0.000283	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TGFBR1—prostate cancer	4.17e-05	0.000283	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—AKR1C3—prostate cancer	4.1e-05	0.000279	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PRKACB—prostate cancer	4.08e-05	0.000277	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—TYMS—prostate cancer	4.06e-05	0.000276	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—GSTM1—prostate cancer	4.02e-05	0.000273	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—THBS1—prostate cancer	3.98e-05	0.00027	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PPP3CA—prostate cancer	3.98e-05	0.00027	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—LPL—prostate cancer	3.94e-05	0.000268	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ANXA1—prostate cancer	3.92e-05	0.000266	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PRKCZ—prostate cancer	3.85e-05	0.000261	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CYP1A1—prostate cancer	3.81e-05	0.000259	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—ERCC2—prostate cancer	3.78e-05	0.000257	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PIK3CG—prostate cancer	3.76e-05	0.000256	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—EP300—prostate cancer	3.76e-05	0.000255	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PARP1—prostate cancer	3.71e-05	0.000253	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FGFR4—prostate cancer	3.71e-05	0.000253	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CALCA—prostate cancer	3.67e-05	0.000249	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—SRC—prostate cancer	3.65e-05	0.000248	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CXCL12—prostate cancer	3.58e-05	0.000244	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—VEGFA—prostate cancer	3.56e-05	0.000242	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—MTHFR—prostate cancer	3.55e-05	0.000241	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PPARA—prostate cancer	3.48e-05	0.000237	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PIK3CG—prostate cancer	3.41e-05	0.000232	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CASP9—prostate cancer	3.37e-05	0.000229	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PIK3CD—prostate cancer	3.3e-05	0.000225	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CAV1—prostate cancer	3.27e-05	0.000223	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NGFR—prostate cancer	3.27e-05	0.000222	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PRKCQ—prostate cancer	3.27e-05	0.000222	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—TGFB1—prostate cancer	3.27e-05	0.000222	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MAP3K7—prostate cancer	3.23e-05	0.00022	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.13e-05	0.000213	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FGF10—prostate cancer	3.11e-05	0.000211	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ADRB2—prostate cancer	3.07e-05	0.000209	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—JAK2—prostate cancer	3.03e-05	0.000206	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—KRAS—prostate cancer	3.02e-05	0.000206	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—MAP2K1—prostate cancer	3.02e-05	0.000205	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PIK3CD—prostate cancer	3e-05	0.000204	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—VAV3—prostate cancer	3e-05	0.000204	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PIK3CG—prostate cancer	2.98e-05	0.000203	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TGFBR2—prostate cancer	2.96e-05	0.000201	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ITPR1—prostate cancer	2.91e-05	0.000198	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PIK3CB—prostate cancer	2.88e-05	0.000196	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—INS—prostate cancer	2.82e-05	0.000192	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IGF1R—prostate cancer	2.78e-05	0.000189	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—PIK3CA—prostate cancer	2.78e-05	0.000189	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—CXCL8—prostate cancer	2.77e-05	0.000188	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—CREBBP—prostate cancer	2.76e-05	0.000188	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—JAK2—prostate cancer	2.75e-05	0.000187	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—TP53—prostate cancer	2.69e-05	0.000183	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—LPL—prostate cancer	2.67e-05	0.000181	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—IL2—prostate cancer	2.65e-05	0.00018	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PDGFRB—prostate cancer	2.64e-05	0.00018	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PIK3CD—prostate cancer	2.62e-05	0.000178	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PIK3CB—prostate cancer	2.62e-05	0.000178	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ITGB3—prostate cancer	2.57e-05	0.000175	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—CXCL8—prostate cancer	2.51e-05	0.000171	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ERBB3—prostate cancer	2.5e-05	0.00017	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FGFR2—prostate cancer	2.49e-05	0.00017	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—NOS3—prostate cancer	2.48e-05	0.000168	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—IL2—prostate cancer	2.4e-05	0.000163	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TERT—prostate cancer	2.39e-05	0.000163	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—HIF1A—prostate cancer	2.29e-05	0.000156	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PIK3CB—prostate cancer	2.28e-05	0.000155	CbGpPWpGaD
Ridogrel—TBXA2R—Hemostasis—AKT1—prostate cancer	2.27e-05	0.000154	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PTGS2—prostate cancer	2.26e-05	0.000154	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—LEP—prostate cancer	2.23e-05	0.000152	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CAV1—prostate cancer	2.21e-05	0.000151	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—KDR—prostate cancer	2.19e-05	0.000149	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ESR1—prostate cancer	2.13e-05	0.000145	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—BAD—prostate cancer	2.08e-05	0.000142	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—APC—prostate cancer	2.02e-05	0.000137	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PIK3CG—prostate cancer	2.02e-05	0.000137	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IRS1—prostate cancer	1.99e-05	0.000136	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—EGF—prostate cancer	1.99e-05	0.000136	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PTEN—prostate cancer	1.97e-05	0.000134	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—GSK3B—prostate cancer	1.94e-05	0.000132	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—INS—prostate cancer	1.91e-05	0.00013	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—EP300—prostate cancer	1.88e-05	0.000128	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CREBBP—prostate cancer	1.87e-05	0.000127	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IGF1—prostate cancer	1.85e-05	0.000126	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—EGFR—prostate cancer	1.84e-05	0.000125	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MAP2K1—prostate cancer	1.78e-05	0.000121	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PIK3CD—prostate cancer	1.77e-05	0.000121	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—PIK3CA—prostate cancer	1.76e-05	0.000119	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SERPINE1—prostate cancer	1.75e-05	0.000119	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—KRAS—prostate cancer	1.74e-05	0.000118	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—FGF2—prostate cancer	1.7e-05	0.000115	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—NOS3—prostate cancer	1.67e-05	0.000114	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—JAK2—prostate cancer	1.63e-05	0.000111	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—PIK3CA—prostate cancer	1.59e-05	0.000108	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MDM2—prostate cancer	1.59e-05	0.000108	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—ERBB2—prostate cancer	1.57e-05	0.000106	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PIK3CB—prostate cancer	1.55e-05	0.000105	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CXCL8—prostate cancer	1.48e-05	0.000101	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CDKN1B—prostate cancer	1.45e-05	9.86e-05	CbGpPWpGaD
Ridogrel—TBXA2R—GPCR downstream signaling—AKT1—prostate cancer	1.43e-05	9.75e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CASP3—prostate cancer	1.42e-05	9.66e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IL2—prostate cancer	1.42e-05	9.65e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—IL6—prostate cancer	1.41e-05	9.6e-05	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—PIK3CA—prostate cancer	1.39e-05	9.47e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CCND1—prostate cancer	1.38e-05	9.41e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CTNNB1—prostate cancer	1.37e-05	9.31e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MMP9—prostate cancer	1.34e-05	9.13e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—CDKN1A—prostate cancer	1.34e-05	9.1e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PTEN—prostate cancer	1.34e-05	9.08e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling by GPCR—AKT1—prostate cancer	1.3e-05	8.86e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—EP300—prostate cancer	1.27e-05	8.66e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—SRC—prostate cancer	1.24e-05	8.42e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—VEGFA—prostate cancer	1.21e-05	8.2e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—STAT3—prostate cancer	1.19e-05	8.12e-05	CbGpPWpGaD
Ridogrel—TBXAS1—Metabolism—AKT1—prostate cancer	1.14e-05	7.74e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—MYC—prostate cancer	1.11e-05	7.54e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TGFB1—prostate cancer	1.11e-05	7.53e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—EGFR—prostate cancer	1.09e-05	7.38e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—KRAS—prostate cancer	1.03e-05	6.97e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—PIK3CA—prostate cancer	9.42e-06	6.4e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—TP53—prostate cancer	9.11e-06	6.2e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—IL6—prostate cancer	8.34e-06	5.67e-05	CbGpPWpGaD
Ridogrel—TBXA2R—Signaling Pathways—AKT1—prostate cancer	7.7e-06	5.23e-05	CbGpPWpGaD
